A safety warning has been issued for users of Mounjaro following the discovery of counterfeit versions of the injectable medication being distributed to the public. The Medicines and Healthcare products Regulatory Agency (MHRA) announced that specific batches of the pen, a prescription medicine approved for weight management, have been recalled after an online pharmacy supplied a non-compliant version. The alert, released on February 24, specifically concerns pre-filled pens that do not meet safety standards.

The recall has identified five affected Mounjaro pens distributed through the Private Pharmacy Clinic in Birmingham. Importantly, Mounjaro KwikPen 7.5mg with a certain batch code has been confirmed to be safe and is not part of this warning. Users are urged to check their batch numbers against the recall notice to ensure they are not at risk of using a falsified product, which could pose health risks.

This alert highlights the ongoing issue of counterfeit medications in the pharmaceutical industry and the need for vigilance among consumers. Authorities are stressing the importance of ensuring that medications are sourced from reputable pharmacies to safeguard health and well-being. The situation reminds users to remain informed and proactive about their medication safety, especially with the increasing prevalence of online pharmacies.